nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—CNR2—lymphoid tissue—acquired immunodeficiency syndrome	0.0203	0.185	CbGeAlD
Nabilone—CNR2—blood—acquired immunodeficiency syndrome	0.0191	0.174	CbGeAlD
Nabilone—CNR2—nervous system—acquired immunodeficiency syndrome	0.0155	0.142	CbGeAlD
Nabilone—CNR2—central nervous system—acquired immunodeficiency syndrome	0.0149	0.136	CbGeAlD
Nabilone—CNR2—brain—acquired immunodeficiency syndrome	0.0118	0.108	CbGeAlD
Nabilone—CNR1—lung—acquired immunodeficiency syndrome	0.0116	0.106	CbGeAlD
Nabilone—CNR1—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.00955	0.0496	CbGpPWpGaD
Nabilone—CNR1—brain—acquired immunodeficiency syndrome	0.00824	0.0753	CbGeAlD
Nabilone—CNR1—lymph node—acquired immunodeficiency syndrome	0.00796	0.0727	CbGeAlD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00748	0.0388	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00587	0.0305	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00569	0.0296	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00453	0.0235	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00447	0.0232	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.0041	0.0213	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00355	0.0185	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00345	0.0179	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.00344	0.0179	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00321	0.0167	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00318	0.0165	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00312	0.0162	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00299	0.0155	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00299	0.0155	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00295	0.0153	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00292	0.0152	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.0028	0.0145	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00278	0.0144	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00271	0.0141	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00253	0.0131	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.0025	0.013	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00245	0.0127	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00238	0.0124	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00238	0.0124	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00235	0.0122	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00235	0.0122	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00232	0.012	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00229	0.0119	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00228	0.0118	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.0022	0.0114	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00218	0.0113	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00213	0.0111	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00205	0.0107	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00199	0.0103	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00193	0.01	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.0019	0.00988	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00187	0.0097	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00187	0.0097	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00181	0.00941	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00181	0.00941	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00181	0.0094	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00179	0.00928	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00177	0.00919	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00173	0.00896	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00167	0.00868	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00163	0.00847	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00161	0.00836	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.0016	0.00831	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00151	0.00785	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00149	0.00776	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00142	0.00738	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00142	0.00738	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00142	0.00738	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00139	0.00721	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00138	0.00716	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00135	0.00703	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00128	0.00665	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00126	0.00652	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00124	0.00645	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00109	0.00568	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00109	0.00566	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00108	0.00562	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00105	0.00543	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00105	0.00543	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00102	0.00532	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00102	0.00532	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000989	0.00514	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000975	0.00506	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000946	0.00491	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00093	0.00483	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00093	0.00483	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000858	0.00446	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000855	0.00444	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000821	0.00426	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000821	0.00426	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000804	0.00417	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000804	0.00417	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000779	0.00405	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000776	0.00403	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000767	0.00398	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000742	0.00385	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00073	0.00379	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00073	0.00379	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000707	0.00367	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000702	0.00364	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000697	0.00362	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000646	0.00335	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000637	0.00331	CbGpPWpGaD
Nabilone—Headache—Didanosine—acquired immunodeficiency syndrome	0.000612	0.000876	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000611	0.00317	CbGpPWpGaD
Nabilone—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000611	0.000875	CcSEcCtD
Nabilone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00061	0.000874	CcSEcCtD
Nabilone—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000609	0.000873	CcSEcCtD
Nabilone—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000609	0.000873	CcSEcCtD
Nabilone—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000609	0.000873	CcSEcCtD
Nabilone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000608	0.000871	CcSEcCtD
Nabilone—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000608	0.000871	CcSEcCtD
Nabilone—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000607	0.00087	CcSEcCtD
Nabilone—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000607	0.00087	CcSEcCtD
Nabilone—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000606	0.000868	CcSEcCtD
Nabilone—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000606	0.000868	CcSEcCtD
Nabilone—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000605	0.000866	CcSEcCtD
Nabilone—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000605	0.000866	CcSEcCtD
Nabilone—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000604	0.000865	CcSEcCtD
Nabilone—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000603	0.000864	CcSEcCtD
Nabilone—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000602	0.000863	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000602	0.00313	CbGpPWpGaD
Nabilone—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000602	0.000862	CcSEcCtD
Nabilone—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000601	0.000861	CcSEcCtD
Nabilone—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.0006	0.000859	CcSEcCtD
Nabilone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000599	0.000858	CcSEcCtD
Nabilone—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000599	0.000858	CcSEcCtD
Nabilone—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000598	0.000857	CcSEcCtD
Nabilone—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000598	0.000856	CcSEcCtD
Nabilone—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000598	0.000856	CcSEcCtD
Nabilone—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000598	0.000856	CcSEcCtD
Nabilone—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000596	0.000853	CcSEcCtD
Nabilone—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000596	0.000853	CcSEcCtD
Nabilone—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000595	0.000853	CcSEcCtD
Nabilone—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000594	0.000851	CcSEcCtD
Nabilone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000591	0.000847	CcSEcCtD
Nabilone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000591	0.000846	CcSEcCtD
Nabilone—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00059	0.000846	CcSEcCtD
Nabilone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00059	0.000846	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00059	0.000845	CcSEcCtD
Nabilone—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000589	0.000845	CcSEcCtD
Nabilone—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000586	0.00084	CcSEcCtD
Nabilone—Pain—Indinavir—acquired immunodeficiency syndrome	0.000586	0.00084	CcSEcCtD
Nabilone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000586	0.000839	CcSEcCtD
Nabilone—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000585	0.000839	CcSEcCtD
Nabilone—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000584	0.000837	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000584	0.00303	CbGpPWpGaD
Nabilone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000583	0.000836	CcSEcCtD
Nabilone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000582	0.000835	CcSEcCtD
Nabilone—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000582	0.000835	CcSEcCtD
Nabilone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000582	0.000834	CcSEcCtD
Nabilone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000581	0.000833	CcSEcCtD
Nabilone—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000581	0.000833	CcSEcCtD
Nabilone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00058	0.000831	CcSEcCtD
Nabilone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00058	0.000831	CcSEcCtD
Nabilone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000579	0.00083	CcSEcCtD
Nabilone—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000579	0.000829	CcSEcCtD
Nabilone—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000578	0.000828	CcSEcCtD
Nabilone—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000578	0.000828	CcSEcCtD
Nabilone—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000577	0.000827	CcSEcCtD
Nabilone—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000577	0.000827	CcSEcCtD
Nabilone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000576	0.000825	CcSEcCtD
Nabilone—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000575	0.000824	CcSEcCtD
Nabilone—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000575	0.000824	CcSEcCtD
Nabilone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000575	0.000824	CcSEcCtD
Nabilone—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000573	0.000821	CcSEcCtD
Nabilone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000571	0.000819	CcSEcCtD
Nabilone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00057	0.000817	CcSEcCtD
Nabilone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000568	0.000814	CcSEcCtD
Nabilone—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000566	0.000812	CcSEcCtD
Nabilone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000565	0.000809	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000564	0.000809	CcSEcCtD
Nabilone—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000564	0.000807	CcSEcCtD
Nabilone—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000563	0.000806	CcSEcCtD
Nabilone—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000562	0.000806	CcSEcCtD
Nabilone—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000562	0.000806	CcSEcCtD
Nabilone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000562	0.000806	CcSEcCtD
Nabilone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000561	0.000803	CcSEcCtD
Nabilone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00056	0.000803	CcSEcCtD
Nabilone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00056	0.000803	CcSEcCtD
Nabilone—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000559	0.000801	CcSEcCtD
Nabilone—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000558	0.0008	CcSEcCtD
Nabilone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000558	0.0008	CcSEcCtD
Nabilone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000558	0.0008	CcSEcCtD
Nabilone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000556	0.000797	CcSEcCtD
Nabilone—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000556	0.000797	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000555	0.00288	CbGpPWpGaD
Nabilone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000554	0.000793	CcSEcCtD
Nabilone—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000554	0.000793	CcSEcCtD
Nabilone—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000554	0.000793	CcSEcCtD
Nabilone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000554	0.000793	CcSEcCtD
Nabilone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000553	0.000792	CcSEcCtD
Nabilone—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000552	0.000791	CcSEcCtD
Nabilone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000552	0.000791	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000551	0.00286	CbGpPWpGaD
Nabilone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000551	0.000789	CcSEcCtD
Nabilone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00055	0.000788	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000549	0.00285	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000549	0.00285	CbGpPWpGaD
Nabilone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000549	0.000786	CcSEcCtD
Nabilone—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000549	0.000786	CcSEcCtD
Nabilone—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000549	0.000786	CcSEcCtD
Nabilone—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000548	0.000785	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000547	0.00284	CbGpPWpGaD
Nabilone—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000547	0.000783	CcSEcCtD
Nabilone—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000546	0.000782	CcSEcCtD
Nabilone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000545	0.000781	CcSEcCtD
Nabilone—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000542	0.000777	CcSEcCtD
Nabilone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000542	0.000777	CcSEcCtD
Nabilone—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000542	0.000776	CcSEcCtD
Nabilone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000542	0.000776	CcSEcCtD
Nabilone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000541	0.000775	CcSEcCtD
Nabilone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000539	0.000772	CcSEcCtD
Nabilone—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000538	0.000772	CcSEcCtD
Nabilone—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000537	0.000769	CcSEcCtD
Nabilone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000536	0.000768	CcSEcCtD
Nabilone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000536	0.000767	CcSEcCtD
Nabilone—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000535	0.000767	CcSEcCtD
Nabilone—Rash—Stavudine—acquired immunodeficiency syndrome	0.000534	0.000766	CcSEcCtD
Nabilone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000534	0.000765	CcSEcCtD
Nabilone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000534	0.000765	CcSEcCtD
Nabilone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000533	0.000764	CcSEcCtD
Nabilone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000533	0.000764	CcSEcCtD
Nabilone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000533	0.000763	CcSEcCtD
Nabilone—Headache—Stavudine—acquired immunodeficiency syndrome	0.000531	0.000761	CcSEcCtD
Nabilone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000531	0.000761	CcSEcCtD
Nabilone—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.00053	0.00076	CcSEcCtD
Nabilone—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00053	0.000759	CcSEcCtD
Nabilone—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00053	0.000759	CcSEcCtD
Nabilone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000529	0.000759	CcSEcCtD
Nabilone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000529	0.000757	CcSEcCtD
Nabilone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000527	0.000754	CcSEcCtD
Nabilone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000526	0.000754	CcSEcCtD
Nabilone—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000526	0.000753	CcSEcCtD
Nabilone—Headache—Abacavir—acquired immunodeficiency syndrome	0.000523	0.00075	CcSEcCtD
Nabilone—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000523	0.000749	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000522	0.000748	CcSEcCtD
Nabilone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000521	0.000747	CcSEcCtD
Nabilone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000521	0.000747	CcSEcCtD
Nabilone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000518	0.000742	CcSEcCtD
Nabilone—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000517	0.000741	CcSEcCtD
Nabilone—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000515	0.000738	CcSEcCtD
Nabilone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000514	0.000737	CcSEcCtD
Nabilone—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000512	0.000733	CcSEcCtD
Nabilone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000512	0.000733	CcSEcCtD
Nabilone—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000511	0.000732	CcSEcCtD
Nabilone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00051	0.000731	CcSEcCtD
Nabilone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000509	0.00073	CcSEcCtD
Nabilone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000508	0.000729	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000507	0.00263	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000507	0.000726	CcSEcCtD
Nabilone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000505	0.000724	CcSEcCtD
Nabilone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000505	0.000723	CcSEcCtD
Nabilone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000504	0.000722	CcSEcCtD
Nabilone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000504	0.000722	CcSEcCtD
Nabilone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000504	0.000721	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000502	0.00072	CcSEcCtD
Nabilone—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000501	0.000718	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.0005	0.0026	CbGpPWpGaD
Nabilone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000499	0.000714	CcSEcCtD
Nabilone—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000498	0.000713	CcSEcCtD
Nabilone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000496	0.000711	CcSEcCtD
Nabilone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000495	0.000709	CcSEcCtD
Nabilone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000494	0.000708	CcSEcCtD
Nabilone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000492	0.000704	CcSEcCtD
Nabilone—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000492	0.000704	CcSEcCtD
Nabilone—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000491	0.000704	CcSEcCtD
Nabilone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00049	0.000702	CcSEcCtD
Nabilone—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00049	0.000702	CcSEcCtD
Nabilone—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00049	0.000702	CcSEcCtD
Nabilone—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00049	0.000702	CcSEcCtD
Nabilone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00049	0.000702	CcSEcCtD
Nabilone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000487	0.000698	CcSEcCtD
Nabilone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000485	0.000695	CcSEcCtD
Nabilone—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000485	0.000695	CcSEcCtD
Nabilone—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000479	0.000687	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000479	0.000687	CcSEcCtD
Nabilone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000477	0.000683	CcSEcCtD
Nabilone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000476	0.000682	CcSEcCtD
Nabilone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000475	0.000681	CcSEcCtD
Nabilone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000472	0.000677	CcSEcCtD
Nabilone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000472	0.000676	CcSEcCtD
Nabilone—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000471	0.000676	CcSEcCtD
Nabilone—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000471	0.000676	CcSEcCtD
Nabilone—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000469	0.000672	CcSEcCtD
Nabilone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000469	0.000672	CcSEcCtD
Nabilone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000468	0.000671	CcSEcCtD
Nabilone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000468	0.000671	CcSEcCtD
Nabilone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000468	0.00067	CcSEcCtD
Nabilone—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000465	0.000666	CcSEcCtD
Nabilone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000464	0.000666	CcSEcCtD
Nabilone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000464	0.000665	CcSEcCtD
Nabilone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000463	0.000663	CcSEcCtD
Nabilone—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000462	0.000661	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000458	0.00238	CbGpPWpGaD
Nabilone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000458	0.000656	CcSEcCtD
Nabilone—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000457	0.000655	CcSEcCtD
Nabilone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000456	0.000654	CcSEcCtD
Nabilone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000454	0.000651	CcSEcCtD
Nabilone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000453	0.00065	CcSEcCtD
Nabilone—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000453	0.000649	CcSEcCtD
Nabilone—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000453	0.000649	CcSEcCtD
Nabilone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000453	0.000649	CcSEcCtD
Nabilone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000451	0.000646	CcSEcCtD
Nabilone—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00045	0.000644	CcSEcCtD
Nabilone—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00045	0.000644	CcSEcCtD
Nabilone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000444	0.000637	CcSEcCtD
Nabilone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000443	0.000635	CcSEcCtD
Nabilone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000438	0.000628	CcSEcCtD
Nabilone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000438	0.000627	CcSEcCtD
Nabilone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000436	0.000624	CcSEcCtD
Nabilone—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000436	0.000624	CcSEcCtD
Nabilone—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000436	0.000624	CcSEcCtD
Nabilone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000433	0.000621	CcSEcCtD
Nabilone—Rash—Indinavir—acquired immunodeficiency syndrome	0.000432	0.000619	CcSEcCtD
Nabilone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000432	0.000618	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000431	0.00224	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000431	0.00224	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00043	0.000616	CcSEcCtD
Nabilone—Headache—Indinavir—acquired immunodeficiency syndrome	0.000429	0.000615	CcSEcCtD
Nabilone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000428	0.000613	CcSEcCtD
Nabilone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000424	0.000607	CcSEcCtD
Nabilone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000422	0.000605	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000418	0.00217	CbGpPWpGaD
Nabilone—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000416	0.000596	CcSEcCtD
Nabilone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000416	0.000596	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000412	0.00214	CbGpPWpGaD
Nabilone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000412	0.00059	CcSEcCtD
Nabilone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000411	0.000589	CcSEcCtD
Nabilone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00041	0.000587	CcSEcCtD
Nabilone—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000408	0.000585	CcSEcCtD
Nabilone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000408	0.000584	CcSEcCtD
Nabilone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000407	0.000583	CcSEcCtD
Nabilone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000406	0.000582	CcSEcCtD
Nabilone—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000406	0.000581	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000406	0.00211	CbGpPWpGaD
Nabilone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000405	0.000581	CcSEcCtD
Nabilone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000396	0.000567	CcSEcCtD
Nabilone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000394	0.000564	CcSEcCtD
Nabilone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000392	0.000562	CcSEcCtD
Nabilone—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000391	0.00056	CcSEcCtD
Nabilone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00039	0.000559	CcSEcCtD
Nabilone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00039	0.000559	CcSEcCtD
Nabilone—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000388	0.000556	CcSEcCtD
Nabilone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000388	0.000555	CcSEcCtD
Nabilone—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000385	0.000551	CcSEcCtD
Nabilone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000379	0.000543	CcSEcCtD
Nabilone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000377	0.000541	CcSEcCtD
Nabilone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000377	0.00054	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000377	0.00196	CbGpPWpGaD
Nabilone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000372	0.000533	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000368	0.00191	CbGpPWpGaD
Nabilone—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000368	0.000527	CcSEcCtD
Nabilone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000365	0.000522	CcSEcCtD
Nabilone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000364	0.000522	CcSEcCtD
Nabilone—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000361	0.000517	CcSEcCtD
Nabilone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000361	0.000517	CcSEcCtD
Nabilone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00036	0.000516	CcSEcCtD
Nabilone—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000359	0.000514	CcSEcCtD
Nabilone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000351	0.000502	CcSEcCtD
Nabilone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000348	0.000498	CcSEcCtD
Nabilone—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000348	0.000498	CcSEcCtD
Nabilone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000347	0.000498	CcSEcCtD
Nabilone—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000345	0.000495	CcSEcCtD
Nabilone—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00034	0.000488	CcSEcCtD
Nabilone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000334	0.000479	CcSEcCtD
Nabilone—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000332	0.000475	CcSEcCtD
Nabilone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000331	0.000475	CcSEcCtD
Nabilone—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000329	0.000472	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000328	0.0017	CbGpPWpGaD
Nabilone—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000327	0.000469	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000323	0.00168	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000318	0.00165	CbGpPWpGaD
Nabilone—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000312	0.000448	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000295	0.00153	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000289	0.0015	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000218	0.00113	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000216	0.00112	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000171	0.000886	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.00017	0.000882	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000128	0.000664	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.0001	0.000521	CbGpPWpGaD
